Tirzepatide

Tirzepatide acts on two hormone receptors, GIP and GLP-1, that help control appetite and blood sugar. It can reduce hunger and help some adults eat less. Results vary. A licensed physician in your state reviews your health history to decide whether tirzepatide is appropriate for you.

Zepbound and Mounjaro are FDA-approved brand medicines containing tirzepatide, but they have different approved uses. Compounded tirzepatide is prepared by a licensed pharmacy for one patient and is not FDA-approved. A licensed physician in your state decides which treatment, if any, is appropriate for your health needs.

Tirzepatide for weight management may be appropriate for adults with obesity, or adults who are overweight and have a weight-related health condition. Meeting weight criteria does not guarantee a prescription. A licensed physician in your state reviews your health history, medicines, and risks before deciding whether treatment is appropriate.

Tirzepatide is injected under the skin once a week, following your prescription and product instructions. Use the prescribed dose, and do not increase it on your own. A licensed physician in your state sets your schedule. Ask the pharmacy to explain any unclear label or syringe markings before injecting.

There is no set amount of weight you will lose with tirzepatide. Results vary. Changes usually develop over months, not days, and depend on your health, dose, eating habits, activity, and ability to stay on treatment. Your physician can help set realistic goals and review whether the medicine remains appropriate.

Tirzepatide can cause nausea, diarrhea, vomiting, constipation, stomach pain, and indigestion. Serious risks include pancreatitis, gallbladder problems, dehydration-related kidney injury, and severe allergic reactions. Contact your physician about ongoing symptoms. Get urgent care for severe belly pain, trouble breathing, fainting, or swelling of your face, lips, tongue, or throat.

Yes. Tirzepatide slows stomach emptying, which can affect oral medicines. It can also raise the risk of low blood sugar when used with insulin or certain diabetes medicines. Birth control pills may be less effective. Tell your physician about every medicine and supplement you use before starting treatment.

For FDA-approved tirzepatide products, take a missed dose within four days, or 96 hours. If more time has passed, skip it and take the next dose on your usual day. Do not double doses. For a compounded prescription, confirm the instructions with your pharmacist or prescribing physician.

Tirzepatide should not be used for weight loss during pregnancy. If you become pregnant, stop weight-loss treatment and contact your prescribing physician promptly. Discuss plans for pregnancy before starting or continuing treatment. Breastfeeding requires an individual medical review because information about effects on a nursing infant remains limited.

Appetite can return and weight regain can occur after stopping tirzepatide. Results vary. If you have diabetes, blood sugar may rise as well. Talk with your prescribing physician before stopping or switching so you have a plan for monitoring, nutrition, activity, and any replacement medicine you may need.